Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| 1 |
Gilead Sciences
GILD
|
$238M |
| 2 |
Johnson & Johnson
JNJ
|
$224M |
| 3 |
MON
Monsanto Co
MON
|
$219M |
| 4 |
AET
Aetna Inc
AET
|
$215M |
| 5 |
Broadcom
AVGO
|
$179M |
Top Sells
| 1 |
Bristol-Myers Squibb
BMY
|
$242M |
| 2 |
Microsoft
MSFT
|
$232M |
| 3 |
Alphabet (Google) Class C
GOOG
|
$205M |
| 4 |
Home Depot
HD
|
$188M |
| 5 |
Nike
NKE
|
$187M |
Sector Composition
| 1 | Financials | 14.12% |
| 2 | Technology | 13.1% |
| 3 | Healthcare | 12.08% |
| 4 | Industrials | 10.99% |
| 5 | Consumer Staples | 8.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Mastercard
MA
$538B
| $582M | 0.92% | 5,641,400 -2,700 | -0% | -$279K |
|
2
Colgate-Palmolive
CL
$67.9B
| $553M | 0.88% | 8,453,600 +1,605,600 | +23% | +$105M |
|
3
Novo Nordisk
NVO
$251B
| $500M | 0.79% | 13,945,900 -707,600 | -5% | -$25.4M |
|
|
LLTC
4
DELISTED
Linear Technology Corp
LLTC
| $482M | 0.76% | 7,733,600 -981,300 | -11% | -$61.2M |
|
5
Costco
COST
$418B
| $451M | 0.71% | 2,819,713 +733,500 | +35% | +$117M |
|
6
NetEase
NTES
$86.2B
| $434M | 0.69% | 2,013,900 +20,800 | +1% | +$4.48M |
|
|
7
Johnson & Johnson
JNJ
$427B
| $394M | 0.62% | 3,423,100 +1,948,000 | +132% | +$224M |
|
|
8
Gilead Sciences
GILD
$140B
| $378M | 0.6% | 5,274,948 +3,327,900 | +171% | +$238M |
|
9
Walt Disney
DIS
$213B
| $378M | 0.6% | 3,623,907 +970,700 | +37% | +$101M |
|
10
Chubb
CB
$110B
| $378M | 0.6% | 2,857,461 +1,147,400 | +67% | +$152M |
|
|
AET
11
DELISTED
Aetna Inc
AET
| $353M | 0.56% | 2,842,782 +1,737,100 | +157% | +$215M |
|
12
NVIDIA
NVDA
$4.24T
| $330M | 0.52% | 3,094,700 -104,900 | -3% | -$11.2M |
|
13
VeriSign
VRSN
$25.5B
| $324M | 0.51% | 4,263,376 -450,000 | -10% | -$34.2M |
|
14
Cboe Global Markets
CBOE
$24.7B
| $324M | 0.51% | 4,386,100 -79,900 | -2% | -$5.9M |
|
|
MON
15
DELISTED
Monsanto Co
MON
| $302M | 0.48% | 2,865,800 +2,080,400 | +265% | +$219M |
|
16
Humana
HUM
$36.5B
| $298M | 0.47% | 1,460,300 +546,596 | +60% | +$112M |
|
|
17
Alphabet (Google) Class A
GOOGL
$2.57T
| $281M | 0.44% | 354,200 -169,848 | -32% | -$135M |
|
18
Walmart
WMT
$774B
| $274M | 0.43% | 3,959,100 +1,164,600 | +42% | +$80.5M |
|
19
Duke Energy
DUK
$95.3B
| $264M | 0.42% | 3,396,267 +113,300 | +3% | +$8.79M |
|
20
F5
FFIV
$18B
| $261M | 0.41% | 1,804,874 +286,800 | +19% | +$41.5M |
|
21
Amgen
AMGN
$155B
| $260M | 0.41% | 1,778,645 -117,696 | -6% | -$17.2M |
|
22
Domino's
DPZ
$15.6B
| $257M | 0.41% | 1,613,500 +188,900 | +13% | +$30.1M |
|
23
Crown Castle
CCI
$43.2B
| $256M | 0.41% | 2,954,903 +1,128,703 | +62% | +$97.9M |
|
24
Entergy
ETR
$39.3B
| $256M | 0.4% | 3,482,300 +258,500 | +8% | +$19M |
|
25
American Electric Power
AEP
$59.4B
| $245M | 0.39% | 3,887,600 +558,392 | +17% | +$35.2M |
|